- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MedPACS links DICOM with PCs
PACS software developer MedPACS Displaysis bringing ACR-NEMA's DICOM 3.0 standard to the masses. The Hartland,WI, company has released MedPACS 100, a software package thatenables off-the-shelf PCs to receive, view and manipulate DICOM3.0 images. The
PACS software developer MedPACS Displaysis bringing ACR-NEMA's DICOM 3.0 standard to the masses. The Hartland,WI, company has released MedPACS 100, a software package thatenables off-the-shelf PCs to receive, view and manipulate DICOM3.0 images.
The software is intended to be used as part of a primary diagnosticworkstation for MRI and CT images, either at scanner sites orat remote locations. MedPACS 100 features commands such as windowlevel, measure distance, region of interest and cine of imagesat up to 30 frames per second. Several different display modesallow real-time comparison of old and new MRI and CT studies.
The system's screen resolution is 1024 x 768 pixels in 250shades of gray. Images can be output to plain paper laser jetprinters or cameras. DICOM images may be received over Ethernet,ISDN, switched-56 or voice-grade phone lines at speeds as fastas eight seconds per image.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
